Skip to content

Xencor XNCR Long-Term Debt

Long-Term Debt at other companies

Amgen logo
AmgenAMGN
$51.89B-3.9%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$1.99B+0.1%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$174.99M+77.4%
XER
Xeris Biopharma Holdings, Inc.XERS
$221.22M+1.6%
XOMA Corporation logo
XOMA CorporationXOMA
$88.83M-11.1%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$42.15B-8.7%

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
Operating cash flow-$67.6M-317%
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.07B+76.3%
Enterprise value$1.23B+55.9%
P/S11×+6.2×

Profitability

See full
Operating margin-217.9%+425pp
Net margin-177.1%+16.5pp
FCF margin-194%+166pp

Returns & leverage

See full
Return on equity-29.8%-2.7pp
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's long-term debt?
Xencor (XNCR) reported long-term debt of $82.12M in Q1 2026.
How has Xencor's long-term debt changed year-over-year?
Xencor's long-term debt decreased by 19.4% year-over-year, from $101.84M to $82.12M.
What does long-term debt mean?
Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.